Company / Current Liabilities
Imunon, Inc. Current Liabilities History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$7.4M
FY2023
5-year range
$6.8M / $10.0M
FY2019-FY2023
Trend
-26.4%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 7 years, ranging from $6M in FY2018 to $10M in FY2022.
Based on SEC 10-K filings.
$7M in FY2023 with a 5-year CAGR of +3.9%.
Increased from $7M to $7M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +3.1%
- 5-Year CAGR
- +3.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +3.9%, indicating consistent growth.
- In FY2023, current liabilities decreased 26.4% year-over-year.
- Peak current liabilities was recorded in FY2022.
- Lowest current liabilities in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $7.4M | -26.4% |
| FY2022 | $10.0M | +48.3% |
| FY2021 | $6.8M | +0.2% |
| FY2020 | $6.8M | -14.5% |
| FY2019 | $7.9M | +29.3% |
| FY2018 | $6.1M | -34.7% |
| FY2015 | $9.3M | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026